Changing Epidemiology of Outpatient Bacteremia in 3- to 36-Month-Old Children After the Introduction of the Heptavalent-Conjugated Pneumococcal Vaccine
- 1 April 2006
- journal article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 25 (4), 293-300
- https://doi.org/10.1097/01.inf.0000207485.39112.bf
Abstract
The introduction of routine vaccination with heptavalent conjugated pneumococcal vaccine has changed the overall incidence of bacteremia in children 3 months-3 years old. To describe the changing incidence and etiology of bacteremia in previously healthy toddlers presenting to outpatient clinical settings. Retrospective case series of all blood cultures obtained between September 1998 and August 2003 in Kaiser Permanente Northern California outpatient clinics and emergency departments from previously healthy children 3 months-3 years old. Implementation of routine vaccination with the conjugated pneumococcal vaccine resulted in an 84% reduction of Streptococcus pneumoniae bacteremia (1.3-0.2%) and a 67% reduction in overall bacteremia (1.6-0.7%) in the study population. The rate of blood culture isolation of contaminating organisms remained unchanged at 1.8%; therefore, by the end of the study, >70% of organisms identified in blood cultures were contaminants. During the 5 study years, total blood cultures drawn decreased by 35% in outpatient pediatric clinics but remained unchanged in emergency departments. By 2003, one-third of all pathogenic organisms isolated from blood cultures were Escherichia coli, one-third were non-vaccine serotype S. pneumoniae, the majority of the remaining one-third were Staphylococcus aureus, Salmonella spp., Neisseria meningitidis and Streptococcus pyogenes. In our population of children routinely immunized with the conjugated pneumococcal vaccine, a white blood cell count >15,000 by itself is a poor predictor of bacteremia in the febrile toddler (sensitivity, 74.0%; specificity, 54.5%; positive predictive value, 1.5%; negative predictive value, 99.5%). In the United States, routine vaccinations with Haemophilus influenzae type b and S. pneumoniae vaccines have made bacteremia in the previously healthy toddler a rare event. As the incidence of pneumococcal bacteremia has decreased, E. coli, Salmonella spp. and Staphylococcus aureus have increased in relative importance. The use of the white blood cell count alone to guide the empiric use of antibiotics is not indicated. New guidelines are needed to approach the previously healthy febrile toddler in the outpatient setting.Keywords
This publication has 25 references indexed in Scilit:
- Population-Based Impact of Pneumococcal Conjugate Vaccine in Young ChildrenPediatrics, 2004
- Use of DNA fingerprinting in decision making for considering closure of neonatal intensive care units because of Pseudomonas aeruginosa bloodstream infectionsThe Pediatric Infectious Disease Journal, 2004
- Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate VaccineNew England Journal of Medicine, 2003
- Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in childrenThe Pediatric Infectious Disease Journal, 2000
- Management of the Young Febrile Child: A Commentary on Recent Practice GuidelinesPediatrics, 1997
- Practice guideline for the management of infants and children 0 to 36 months of age with fever without sourceAnnals of Emergency Medicine, 1993
- Outcome of children with occult bacteremia caused by Haemophilus influenzae type bThe Pediatric Infectious Disease Journal, 1992
- Antibiotic Administration to Treat Possible Occult Bacteremia in Febrile ChildrenNew England Journal of Medicine, 1987
- Risk factors for development of bacterial meningitis among children with occult bacteremiaThe Journal of Pediatrics, 1986
- A comparative study of the prevalence, outcome, and prediction of bacteremia in childrenThe Journal of Pediatrics, 1983